Senior insider sale
Chief Scientific Officer at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$229.6K
16.68K shares
What this filing means
LORRAIN DANIEL S. plans to sell 16.68K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $229.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001950047-26-005377
Officer· Chief Scientific Officer
Since Mar 2026
16.68K
Shares to sell
$229.6K
Approx. market value
4.17K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
5/9/2017
4.17KTotal acquired4.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/9/2017 | Restricted Stock Units N/A | 4.17K | — |
| Total | 4.17K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.17K
Market value
$54.7K
5/1/2026
—Completed
Units to sell
4.17K
Market value
$56.0K
4/6/2026
—Completed
Units to sell
4.17K
Market value
$62.6K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.17K
Market value
$56.3K
6/1/2026
Total
Units
16.68K
Value
$229.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/1/2026 | 4.17K | $54.7K | — | Completed |
4/6/2026 | 4.17K | $56.0K | — | Completed |
3/2/2026 | 4.17K | $62.6K | — | Completed |
| Planned — Approximate Date | ||||
6/1/2026 | 4.17K | $56.3K | NASDAQ | Planned |
| Total | 16.68K | $229.6K | ||